Xtandi 80 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FWQV6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,170
Award facts
- Contract value 100% obligated
- $4,169.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,169.59 by the Defense Logistics Agency on September 5, 2025, for the supply of Xtandi 80 mg tablets (60-count units). The contract represents a delivery order under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499.999 billion through November 2026. No set-aside designation was utilized for this award, and the ultimate completion date is September 8, 2025, with performance occurring at the contractor's facility in Park Ridge, Illinois.
This delivery order supports the Defense Logistics Agency's mission to supply pharmaceutical products to Department of Defense healthcare facilities worldwide. Xtandi is a prescription oncology medication, reflecting DMS Pharmaceutical Group's established role as a critical supplier of branded and generic prescription drugs, biologics, and medical consumables to military health systems. The contractor's consistent track record of delivering diverse pharmaceutical products through the DLA's SPE2DB program demonstrates its capability to meet federal healthcare supply requirements efficiently and reliably.
Quick answers
Who was awarded contract SPE2DB25FWQV6?
SPE2DB25FWQV6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FWQV6 worth?
The government has obligated $4,170 on SPE2DB25FWQV6.
Is contract SPE2DB25FWQV6 an order under another contract?
Yes. SPE2DB25FWQV6 is a delivery order under SPE2DB24D9218, an indefinite delivery contract.
Was contract SPE2DB25FWQV6 competed?
The extent of competition for SPE2DB25FWQV6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award